DEA schedule
Is lacosamide a controlled substance?
Federal schedule for lacosamide from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
Yes. Lacosamide is a Schedule V controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Lacosamide (Schedule V).
Run it in Rivvi
Which 2027 plans near you dropped or restricted lacosamide?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 164 prescription listings from 59 labelers, all Schedule V |
| DEA controlled substances list | Lacosamide: Schedule V |
DEA list entry
| Substance | DEA code | Schedule | Narcotic | Other names | Match |
|---|---|---|---|---|---|
| Lacosamide | 2746 | V | No | Vimpat | Listed by name |
Lacosamide NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 73289-0063 | MOTPOLY XR | capsule, extended release | 100 mg/1 | Aucta Pharmaceuticals, Inc. | CV |
| 73289-0064 | MOTPOLY XR | capsule, extended release | 150 mg/1 | Aucta Pharmaceuticals, Inc. | CV |
| 73289-0065 | MOTPOLY XR | capsule, extended release | 200 mg/1 | Aucta Pharmaceuticals, Inc. | CV |
| 0131-1810 | Vimpat | injection | 10 mg/mL | UCB, Inc. | CV |
| 0131-5410 | Vimpat | solution | 10 mg/mL | UCB, Inc. | CV |
| 0131-2478 | Vimpat | tablet, film coated | 100 mg/1 | UCB, Inc. | CV |
| 0131-2479 | Vimpat | tablet, film coated | 150 mg/1 | UCB, Inc. | CV |
| 0131-2480 | Vimpat | tablet, film coated | 200 mg/1 | UCB, Inc. | CV |
| 0131-2477 | Vimpat | tablet, film coated | 50 mg/1 | UCB, Inc. | CV |
| 13811-207 | Lacosamide | injection | 10 mg/mL | Trigen Laboratories, LLC | CV |
| 14445-406 | Lacosamide | injection | 10 mg/mL | Indoco Remedies Limited | CV |
| 31722-203 | LACOSAMIDE | injection | 10 mg/mL | Camber Pharmaceuticals, Inc. | CV |
| 43598-087 | Lacosamide | injection | 10 mg/mL | Dr. Reddy's Laboratories Inc. | CV |
| 65219-204 | Lacosamide | injection | 10 mg/mL | Fresenius Kabi USA, LLC | CV |
| 68083-480 | Lacosamide | injection | 10 mg/mL | Gland Pharma Limited | CV |
| 69367-352 | Lacosamide | injection | 10 mg/mL | Westminster Pharmaceuticals, LLC | CV |
| 70710-1359 | LACOSAMIDE | injection | 10 mg/mL | Zydus Pharmaceuticals USA Inc. | CV |
| 70710-1886 | LACOSAMIDE | injection | 10 mg/mL | Zydus Pharmaceuticals USA Inc. | CV |
| 70771-1682 | LACOSAMIDE | injection | 10 mg/mL | Zydus Lifesciences Limited | CV |
| 72205-220 | Lacosamide | injection | 10 mg/mL | Novadoz Pharmaceuticals LLC | CV |
| 72266-242 | Lacosamide | injection | 10 mg/mL | Fosun Pharma USA | CV |
| 72603-263 | LACOSAMIDE | injection | 10 mg/mL | NorthStar RxLLC | CV |
| 72865-235 | LACOSAMIDE | injection | 10 mg/mL | XLCare Pharmaceuticals Inc. | CV |
| 83090-012 | Lacosamide | injection | 10 mg/mL | Sintetica US LLC | CV |
| 25021-791 | LACOSAMIDE | injection, solution | 10 mg/mL | Sagent Pharmaceuticals | CV |
| 68462-697 | LACOSAMIDE | injection, solution | 10 mg/mL | GLENMARK PHARMACEUTICALS INC., USA | CV |
| 69543-455 | LACOSAMIDE | injection, solution | 10 mg/mL | Virtus Pharmaceuticals, LLC | CV |
| 70069-471 | LACOSAMIDE | injection, solution | 10 mg/mL | Somerset Therapeutics, LLC | CV |
| 83854-002 | LACOSAMIDE | injection, solution | 10 mg/mL | Anthea Pharma Private Limited | CV |
| 31722-627 | Lacosamide | solution | 10 mg/mL | Camber Pharmaceuticals, Inc. | CV |
| 59651-016 | Lacosamide | solution | 10 mg/mL | Aurobindo Pharma Limited | CV |
| 60687-847 | Lacosamide | solution | 10 mg/mL | American Health Packaging | CV |
| 68462-940 | Lacosamide | solution | 10 mg/mL | Glenmark Pharmaceuticals Limited | CV |
| 69315-318 | Lacosamide | solution | 10 mg/mL | Leading Pharma, LLC | CV |
| 70954-488 | Lacosamide | solution | 10 mg/mL | ANI Pharmaceuticals, Inc. | CV |
| 72162-2637 | Lacosamide | solution | 10 mg/mL | Bryant Ranch Prepack | CV |
| 72205-034 | Lacosamide | solution | 10 mg/mL | Novadoz Pharmaceuticals LLC | CV |
| 72603-305 | Lacosamide | solution | 10 mg/mL | NorthStar Rx LLC | CV |
| 85742-014 | Lacosamide | solution | 10 mg/mL | Kanchan Healthcare Inc | CV |
| 0121-2024 | Lacosamide | solution | 100 mg/10mL | PAI Holdings, LLC dba PAI Pharma | CV |
Showing 40 of 164 listings.
Questions
Is lacosamide a controlled substance?
Yes. Lacosamide is a Schedule V controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Lacosamide (Schedule V).
Is lacosamide a narcotic?
No. The DEA list does not mark lacosamide as a narcotic (NARC = N) and places it in Schedule V.
What schedule is lacosamide?
Lacosamide is Schedule V in the FDA NDC directory, which matches the DEA controlled substances list.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Lacosamide
- What is Lacosamide used for?FDA label uses
- Generic for Motpoly XRFDA Orange Book
- Generic for VimpatFDA Orange Book
- What is Vimpat used for?FDA label uses
- Is Vimpat a controlled substance?Schedule V
- What is Motpoly XR used for?FDA label uses
- Is Motpoly XR a controlled substance?Schedule V
- NDC 0131-1810Lacosamide NDC record
- NDC 0131-2477Lacosamide NDC record
- NDC 0131-2478Lacosamide NDC record
- Schedule V drugs listDEA schedule